Cambridge Cognition appoints new NOMAD and updates on chairman’s past directorships

An update from Cambridge Cognition Holdings ( (GB:COG) ) is now available.

Cambridge Cognition Holdings has appointed Cavendish Capital Markets as its Nominated Adviser and Joint Broker, strengthening its capital markets support while Singer Capital Markets continues as Joint Corporate Broker. The company also disclosed that Chairman Steven Powell previously held directorships at Ribonexus SAS and LCC Therapeutics, both of which subsequently entered liquidation, providing investors with updated governance and regulatory information.

These changes in advisory arrangements may enhance Cambridge Cognition’s access to investors and corporate finance expertise as it pursues growth across its neuroscience technology markets. The board-related disclosures offer additional transparency around the chairman’s past roles in companies that went into liquidation, which may be relevant for shareholder assessment of governance and risk profile.

The most recent analyst rating on (GB:COG) stock is a Hold with a £36.00 price target. To see the full list of analyst forecasts on Cambridge Cognition Holdings stock, see the GB:COG Stock Forecast page.

Spark’s Take on COG Stock

According to Spark, TipRanks’ AI Analyst, COG is a Neutral.

Overall score reflects weak financial performance driven by declining revenue, ongoing losses, and negative operating/free cash flow, partially offset by improved equity on the balance sheet. Technicals are mixed (short-term strength but longer-term downtrend and overbought RSI), while valuation is constrained by loss-making results and no stated dividend yield.

To see Spark’s full report on COG stock, click here.

More about Cambridge Cognition Holdings

Cambridge Cognition Holdings is a neuroscience technology company specialising in digital cognitive assessments that support scientific discovery, accelerate drug development and enhance patient care. Built on curated data and technical expertise, it targets clinical studies, academic research, healthcare providers, and consumer health and wellness markets globally.

Average Trading Volume: 33,718

Technical Sentiment Signal: Hold

Current Market Cap: £17.92M

See more insights into COG stock on TipRanks’ Stock Analysis page.